estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet [Estratest]
RxNorm concept 209251, branded drug (sbd). Prescribable name: Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet.
- RxCUI
- 209251
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/209251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Estratest H.S. 0.625 MG / 1.25 MG Oral Tablet; estrogens, esterified (USP) 0.625 MG / methylTESTOSTERone 1.25 MG Oral Tablet [Estratest]
Related concepts
- methyltestosterone 1.25 MG (SCDC, consists of)
- estrogens, esterified (USP) 0.625 MG (SCDC, consists of)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG [Estratest] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Estratest (BN, has ingredient)
- estrogens, esterified (USP) 0.625 MG / methyltestosterone 1.25 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 209251 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/209251 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 209251. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.